ECIA — what changed in the latest 10-Q
A section-by-section comparison of ECIA's newest periodic SEC filing (10-K/10-Q) against the prior same-form filing: paragraphs added and removed per section, with verbatim excerpts. Purely a deterministic text diff — no similarity scores, no directional read, not investment advice.
Comparing 10-Q · 2025-11-13 vs the prior 10-Q · 2025-08-15
| Section | Outcome | Added | Removed | Minor | Unchanged |
|---|---|---|---|---|---|
| MD&A | Text added/removed | +26 | −16 | ~25 | 5 |
| Market risk (Item 3) | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Controls & procedures | Text added/removed | +1 | −2 | ~5 | 3 |
| Legal proceedings | No paragraph-level changes | 0 | 0 | 0 | 1 |
| Risk factors | No material changes reported (points to the 10-K) | — | — | — | — |
| Other information | Text added/removed | +1 | −2 | 0 | 0 |
Counts are paragraphs; added/removed means text added or removed vs the prior filing — no direction or judgement implied.
Representative excerpts
Up to 5 excerpts of about 300 characters per section, quoted verbatim from the two SEC filings.
MD&A
Text added vs the prior filing · source: 10-Q · 2025-11-13
Net Service revenue. Net service revenue for the quarter ended September 30, 2025, was $46,248 compared to $101,568 for the quarter ended September 30, 2024. This decrease was because of a short delay in services performed under a Master Services Agreement with Vicarious Surgical Inc. This decrease …
Gross profit. Gross profit for the quarter ended September 30, 2025, of $697,333 represented a decrease of 16% from the gross profit of $828,482 for the quarter ended September 30, 2024. Gross profit declined for the quarter ended September 30, 2025, due to reduced sales and an unfavorable change in…
Net loss. Net loss was $267,833 for the quarter ended September 30, 2025, compared to a net loss of $170,262 for the quarter ended September 30, 2024. The increase in net loss for the quarter ended September 30, 2025, was primarily because of reduced sales volume and an unfavorable change in product…
For the six months ended September 30, 2025, compared to the six months ended September 30, 2024.
Net Product revenue. Net product revenue for the six months ended September 30, 2025, was $2,974,634 compared to $3,245,779 for the six months ended September 30, 2024, a decrease of 8%. The decrease in net product revenue is attributable to decreased demand for our products.
Text removed vs the prior filing · source: 10-Q · 2025-08-15
Net Service revenue. Net service revenue for the quarter ended June 30, 2025 was $109,896 compared to $38,971 for the quarter ended June 30, 2024.This increase was primarily because of services performed under a Master Services Agreement with Vicarious Surgical Inc.
Gross profit. Gross profit for the quarter ended June 30, 2025 of $878,459 represented a decrease of 7% from gross profit of $942,663 for the quarter ended June 30, 2024. Gross profit on product net revenue as a percentage of sales (gross margin) was 55% and 58% for the quarters ended June 30, 2025 …
Net loss. Net loss was $41,133 for the quarter ended June 30, 2025 compared to net income of $22,041 for the quarter ended June 30, 2024. The decrease to net income was primarily because of the reduced product sales during the period.
The results of operations for the three months ending June 30, 2025, are not necessarily indicative of the results of operations for all or any part of the balance of the fiscal year.
To date, a significant portion of our operating funds have been provided by issuances of our common stock and warrants, the exercise of stock options to purchase our common stock, loans, and (in some periods) by operating profits. Common stock and additional paid-in capital totaled $24,428,466 from …
Controls & procedures
Text added vs the prior filing · source: 10-Q · 2025-11-13
Our management, comprised of our Chief Executive Officer (CEO) and Principal Financial and Accounting Officer (PFAO), evaluated the effectiveness of our disclosure controls and procedures as of September 30, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-1…
Text removed vs the prior filing · source: 10-Q · 2025-08-15
Management’s Evaluation of Disclosures Controls and Procedures
Our management, comprised of our Chief Executive Officer (CEO) and Principal Financial and Accounting Officer (PFAO), evaluated the effectiveness of our disclosure controls and procedures as of June 30, 2025. The term “disclosure controls and procedures,” as defined in Rules 13a-15(e) and 15d-15(e) …
Other information
Text added vs the prior filing · source: 10-Q · 2025-11-13
During the period ending September 30, 2025, no director or officer adopted or terminated any Rule 10b5-1 trading arrangement or non-Rule 10b5-1 trading arrangement, as each term is defined in Item 408(a) of Regulation S-K.
Text removed vs the prior filing · source: 10-Q · 2025-08-15
Our policy governing transactions in our securities by directors, officers, and employees permits our officers, directors, and certain other persons to enter into trading plans complying with Rule 10b5-1 under the Exchange Act. Generally, under these trading plans, the individual relinquishes contro…
During the three months ended June 30, 2025, none of our directors or executive officers had a Rule 10b5-1 plan in effect.
How to read Risk Factors (Item 1A) in a 10-Q
A 10-Q risk-factor section usually takes one of three forms; this page classifies it as one of:
- Pointer — the filer states there have been no material changes and points back to the annual 10-K risk factors; there is no own risk text to compare this quarter.
- Partial update — the filer carves out specific updated risks ("except as set forth below"); the excerpts show exactly what is new this quarter.
- Restated in full — the quarter carries the complete risk-factor text. When the prior quarter was only a pointer there is no prior full text to diff against, so the page flags the section as restated instead.
This describes the filing structure only — it is never a judgement on whether risk went up or down.
Source: text-level diff of the two SEC EDGAR filings · deterministic (no AI-generated content) · for reference only · not investment advice